Home > LIEGE 2019 preliminary program

LIEGE 2019 preliminary program

It is our pleasure to anounce the preliminary program of the 2019 BELNUC Symposium that will be held in Liege on May 10-12

 

Saturday, May 11, 2019

Developments in total body PET/CT systems

Prof Dr Stefaan Vandenberghe, MEDISIP-ELIS-IBITECH-IMEC, Ghent University, Belgium

PSMA targeted radionuclide therapy

Dr Andrei Gafita, Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases

Prof Dr Marnix Lam, Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

PET in Hodgkin lymphoma

Dr Anne-Ségolène Cottereau, Hopital Cochin, Paris, France

PET in diffuse large B cell lymphoma

Prof Dr Sally F. Barrington, Kings College London and Guy's and St Thomas' PET Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, King's Health Partners, London, UK

Interpretation criteria for FDG PET/CT in multiple myeloma

Prof Dr Cristina Nanni, Azienda Ospedaliero Universitaria Policlinico S.Orsola-Malpighi, Bologna, Italy.

Nanobodies labeled with 225Ac for targeted α-particle therapy

Prof Matthias D’Huyvetter, In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Belgium

 

Sunday, May 12, 2019

Radioiodine therapy in differentiated thyroid cancer with a discussion of the ATA, ETA, EANM, SNMMI “white paper”

Novel aspects in the EANM-SNMMI guidelines on thyroid imaging, radioiodine uptake and therapy in benign diseases

Prof Dr Luca Giovanella, Oncology Institute of Southern Switzerland

Chronic back pain management: The value of CT and MRI and the added value of SPECT/CT

Dr Benedicte Daenen and Dr Gauthier Namur, CHC Liege, Belgium

Can we replace thoraco-abdominal CT by whole-body MRI in oncology?

Dr Francois Cousin, CHU of Liege

Signal and image processing. Deep learning and artificial intelligence

Pr Dimitris Visvikis, INSERM UMR 1101 LaTIM UBO, Brest, France